Smoking as a risk factor for oral candidiasis in HIV-infected adults

J Oral Pathol Med. 2013 Apr;42(4):302-8. doi: 10.1111/jop.12019. Epub 2012 Dec 4.

Abstract

Objective: We aimed to examine if smoking is an independent predictor of oral candidiasis (OC) among HIV-1 infected persons.

Methods: The cross-sectional part of this study evaluated 631 adult dentate HIV-1 seropositive persons examined for OC from 1995-2000 at the University of North Carolina Hospitals in Chapel Hill, NC. In the second part, from the above sample, a total of 283 individuals who were free of HIV-associated oral diseases at baseline were followed up for 2 years to assess incident OC events. Data collected from medical record review, interview questionnaires, and clinical examinations were analyzed using chi-squared tests and t-tests. Logistic regression models were developed for prevalent OC employing the likelihood ratio test, whereas Poisson regression models were developed for assessing cumulative incidence of OC. These models included a variety of independent variables to adjust for confounding.

Results: Thirteen percent of participants had OC only; 4.6% had OC with Oral Hairy Leukoplakia; and 69.7% had neither. Smoking was associated with OC in all models [prevalent OC - current smokers: logistic regression - Odd ratio (95% CI) = 2.5 (1.3, 4.8); Incident OC - current smokers: Poisson regression (main effects model) - Incidence rate ratio (95% CI) = 1.9 (1.1, 3.8)]. Other Poisson regression models suggested evidence for effect modification between CD4 cell count and incident OC by smoking.

Conclusion: Smoking is an independent risk factor for the development of OC in HIV-1 infected persons, and the risk of OC is modified by CD4 cell count which measures strength of the immune system.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • AIDS-Related Opportunistic Infections / etiology*
  • Adult
  • Anti-Retroviral Agents / therapeutic use
  • Antifungal Agents / therapeutic use
  • CD4 Lymphocyte Count
  • Candidiasis, Oral / etiology*
  • Cohort Studies
  • Cross-Sectional Studies
  • Follow-Up Studies
  • HIV Infections / complications*
  • HIV Infections / immunology
  • HIV Seropositivity / complications
  • HIV Seropositivity / immunology
  • Humans
  • Interviews as Topic
  • Leukoplakia, Hairy / etiology
  • Longitudinal Studies
  • Physical Examination
  • Retrospective Studies
  • Risk Factors
  • Smoking / adverse effects*
  • Surveys and Questionnaires

Substances

  • Anti-Retroviral Agents
  • Antifungal Agents